Return
Company Page
Taudia
Taudia is a life sciences diagnostics company developing an ultrasensitive blood-based protein biomarker platform for the detection of neurodegenerative diseases, including Alzheimer's disease. Founded by a team of serial entrepreneurs with prior successful exits to MilliporeSigma and Thermo Fisher Scientific, Taudia's platform is designed to deliver ultra-sensitive performance with simplicity, enabling researchers, biopharma teams, and clinicians to detect critical biomarkers from blood with high precision.
Company Founded in 2024
Healthtech & Biotech